durvalumab

FDA Approves Keytruda for Biliary Cancer, Rivals AstraZeneca’s Imfinzi

Merck’s Keytruda has received FDA approval to treat locally advanced unresectable or metastatic biliary tract cancer, alongside gemcitabine and cisplatin ...